Marketing-authorisation holder · Spain

Pharma Mar S.A.

Spain16 medicines4 countries

16 medicines in 4 countries, as authorisation holder, manufacturer and marketer.

Medicines

Every medicine in the registers under its name, current ones first.

16 medicines

Medicine	Substance	Country	Status	Authorised
Yondelis	Trabectedin	EU (EMA)	Authorised	2007
Yondelis 0.25 mg, poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie	Trabectedin	Netherlands	Authorised	2007
YONDELIS 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION0,25 mg · Polvo para concentrado para solución para perfusión	Trabectedin	Spain	Authorised	2026
YONDELIS 0,25 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION0,25 mg · Polvo para concentrado para solución para perfusión	Trabectedin	Spain	Marketed	2007
Yondelis 1 mg, poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie	Trabectedin	Netherlands	Authorised	2007
YONDELIS 1 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION1 mg · Polvo para concentrado para solución para perfusión	Trabectedin	Spain	Marketed	2007
YONDELIS 1 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION1 mg · Polvo para concentrado para solución para perfusión	Trabectedin	Spain	Authorised	2026
Zepzelca	Lurbinectedin	EU (EMA)	Authorised	2026
ZEPZELCA 2 mg poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie	Lurbinectedin	Netherlands	Authorised	2026
ZEPZELCA 2 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION2 mg · Polvo para concentrado para solución para perfusión	Lurbinectedin	Spain	Authorised	2026
ZEPZELCA 4 mg poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie	Lurbinectedin	Netherlands	Authorised	2026
ZEPZELCA 4 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION4 mg · Polvo para concentrado para solución para perfusión	Lurbinectedin	Spain	Authorised	2026
Aplidin	Plitidepsin	EU (EMA)	Refused
Yondelis	Trabectedin	EU (EMA)	Refused
YONDELIS 0,25mg0,25mg · Pulb. pt.conc. pt.sol. perf.	Trabectedin	Romania	unknown
YONDELIS 1mg1mg · Pulb. pt.conc. pt.sol. perf.	Trabectedin	Romania	unknown

Sources and licences

Country	Medicines	Current	Past	Companies
Spain	6	6	0	Companies All medicines
European Union (EMA)	4	2	2	Companies All medicines
Netherlands	4	4	0	Companies All medicines
Romania	2	0	2	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Anvisa, Brazil

Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.

Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

All 16 sources

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

BDPM / ANSM, HAS and UNCAM, France

BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Medicines and Healthcare products Regulatory Agency, United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.

Licence: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Ministerul Sănătății

Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

Läkemedelsverket, Sweden

Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

Läkemedelsverket, Sweden

Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

Report an error or request removal Corrections from the company itself are welcome.

Pharma Mar S.A.

Medicines

Know your medicines, with the sources.

Pharma Mar S.A.

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Work with Prognia

Spain: more companies